Biomanufacturing Viral Detection and Quantifications Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Offering Type, By Technology, By Application, By End-User, By Region and Competition, 2020-2030F

Description

The Global Biomanufacturing Viral Detection and Quantifications Market was valued at USD 493.46 million in 2024 and is projected to reach USD 835.86 million by 2030, growing at a CAGR of 9.14%. This market encompasses the large-scale production of reagents, instruments, and diagnostic systems used to detect and quantify viral agents in clinical, environmental, and research samples. Integrating biotechnological, molecular biology, and engineering principles, biomanufacturing enables the consistent and scalable development of tools essential for techniques like PCR, ELISA, and other molecular diagnostics. These technologies support the creation of diagnostic kits and high-throughput platforms, including biosensors and microfluidics, which are increasingly used in point-of-care and laboratory settings. The sector plays a critical role in enabling rapid virus detection and measurement, supporting global health systems in their surveillance, diagnosis, and response efforts. Key areas include molecular diagnostics, immunodiagnostics, biosensor technologies, and cell-based assays-all of which contribute to the timely identification and management of viral threats.

Market Overview
Forecast Period	2026-2030
Market Size 2024	USD 493.46 Million
Market Size 2030	USD 835.86 Million
CAGR 2025-2030	9.14%
Fastest Growing Segment	ELISA
Largest Market	Asia Pacific

Key Market Drivers

Increasing Incidence of Viral Diseases

The growing prevalence of viral diseases is a primary driver accelerating the demand for advanced viral detection and quantification tools. As of 2024, the World Health Organization reported over 4.2 million dengue cases globally and more than 95,000 mpox (formerly monkeypox) cases since its outbreak in 2022. These figures reflect the increasing urgency for effective diagnostic tools to identify and contain viral infections early.

Biomanufactured products such as PCR kits, ELISA tests, and CRISPR-based diagnostics are vital for fast and accurate virus detection from clinical and environmental samples. These tools facilitate early diagnosis, rapid treatment initiation, and containment of infectious diseases. In settings where diseases like dengue are endemic, early quantification of viral load is essential to assess disease severity and determine appropriate clinical interventions. As new viral threats emerge, the need for deployable, high-performance diagnostic solutions continues to grow.

Key Market Challenges

Rapidly Evolving Viruses

One of the major challenges in the market is the ability of viruses to mutate rapidly, which can compromise the accuracy and reliability of diagnostic assays. Genetic mutations can affect the regions targeted by primers, probes, or antibodies, resulting in false negatives or decreased assay sensitivity.

To maintain diagnostic accuracy, biomanufacturers must continually update assay formulations to account for emerging variants. This requires ongoing investment in R&D and flexible production systems that can respond to evolving viral genomes. Ensuring optimal binding affinity and specificity under these conditions is complex and resource-intensive, posing a challenge to sustained product performance in the face of dynamic viral evolution.

Key Market Trends

Emerging Infectious Diseases Preparedness

Preparedness for emerging infectious diseases (EIDs) is shaping the future of the biomanufacturing viral detection and quantification market. This trend emphasizes the need for agile and responsive diagnostic capabilities that can be deployed during novel outbreaks.

Manufacturers are prioritizing the development of flexible diagnostic platforms that can quickly adapt to new pathogens. Scalable production and modular assay designs enable rapid shifts in manufacturing focus during global health emergencies. Fast-track regulatory approvals, collaborative efforts with public health agencies, and real-time surveillance capabilities are further reinforcing this trend.

Biomanufactured viral detection tools are not only crucial for diagnostics but also for tracking disease spread, evaluating vaccine effectiveness, and informing public health strategies during outbreaks. The growing emphasis on global health security is driving investment in platforms that support EID surveillance, detection, and response.

Key Market Players

Danaher Corporation
Merck KGaA
New England Biolabs
TAKARA HOLDINGS INC.
Thermo Fisher Scientific Inc.
Agilent Technologies, Inc.
Sartorius AG
Charles River Laboratories
Bio-Rad Laboratories, Inc.
PerkinElmer, Inc

Report Scope:

In this report, the Global Biomanufacturing Viral Detection and Quantifications Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Biomanufacturing Viral Detection and Quantifications Market, By Offering Type:

Consumables
Instruments
Services

Biomanufacturing Viral Detection and Quantifications Market, By Technology:

PCR
ELISA
Flow Cytometry
Plaque Assay
Others

Biomanufacturing Viral Detection and Quantifications Market, By Application:

Blood and Blood Products Manufacturing
Vaccines and Therapeutics Manufacturing
Cellular and Gene Therapy Products Manufacturing
Stem Cell Products Manufacturing
Tissue and Tissue Products Manufacturing

Biomanufacturing Viral Detection and Quantifications Market, By End User:

Life Science Companies
Testing Laboratories
CROs and CDMOs

Biomanufacturing Viral Detection and Quantifications Market, By Region:

North America

United States
Canada
Mexico

Asia-Pacific

China
India
South Korea
Australia
Japan

Europe

Germany
France
United Kingdom
Spain
Italy

South America

Brazil
Argentina
Colombia

Middle East & Africa

South Africa
Saudi Arabia
UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Biomanufacturing Viral Detection and Quantifications Market.

Available Customizations:

Global Biomanufacturing Viral Detection and Quantifications Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

1. Product Overview

1.1. Market Definition
1.2. Scope of the Market
- 1.2.1. Markets Covered
- 1.2.2. Years Considered for Study
- 1.2.3. Key Market Segmentations

2. Research Methodology

2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations

3. Executive Summary

3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Biomanufacturing Viral Detection and Quantifications Market Outlook

5.1. Market Size & Forecast
- 5.1.1. By Value
5.2. Market Share & Forecast
- 5.2.1. By Offering Type (Consumables, Instruments, Services)
- 5.2.2. By Technology (PCR, ELISA, FLOW Cytometry, Plaque Assay, Others)
- 5.2.3. By Application (Blood and Blood Products Manufacturing, Vaccine and Therapeutics Manufacturing, Cellular and Gene Therapy Products Manufacturing, Stem Cell Products Manufacturing, Tissue and tissue Products Manufacturing)
- 5.2.4. By End-User (Life Science Companies, testing Laboratories, CROs and CDMOs)
- 5.2.5. By Company (2024)
- 5.2.6. By Region
5.3. Market Map

6. North America Biomanufacturing Viral Detection and Quantifications Market Outlook

6.1. Market Size & Forecast
- 6.1.1. By Value
6.2. Market Share & Forecast
- 6.2.1. By Offering Type
- 6.2.2. By Technology
- 6.2.3. By Application
- 6.2.4. By End-User
- 6.2.5. By Country
6.3. North America: Country Analysis
- 6.3.1. United States Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 6.3.1.1. Market Size & Forecast
    - 6.3.1.1.1. By Value
  - 6.3.1.2. Market Share & Forecast
    - 6.3.1.2.1. By Offering Type
    - 6.3.1.2.2. By Technology
    - 6.3.1.2.3. By Application
    - 6.3.1.2.4. By End-User
- 6.3.2. Mexico Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 6.3.2.1. Market Size & Forecast
    - 6.3.2.1.1. By Value
  - 6.3.2.2. Market Share & Forecast
    - 6.3.2.2.1. By Offering Type
    - 6.3.2.2.2. By Technology
    - 6.3.2.2.3. By Application
    - 6.3.2.2.4. By End-User
- 6.3.3. Canada Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 6.3.3.1. Market Size & Forecast
    - 6.3.3.1.1. By Value
  - 6.3.3.2. Market Share & Forecast
    - 6.3.3.2.1. By Offering Type
    - 6.3.3.2.2. By Technology
    - 6.3.3.2.3. By Application
    - 6.3.3.2.4. By End-User

7. Europe Biomanufacturing Viral Detection and Quantifications Market Outlook

7.1. Market Size & Forecast
- 7.1.1. By Value
7.2. Market Share & Forecast
- 7.2.1. By Offering Type
- 7.2.2. By Technology
- 7.2.3. By Application
- 7.2.4. By End-User
- 7.2.5. By Country
7.3. Europe: Country Analysis
- 7.3.1. France Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 7.3.1.1. Market Size & Forecast
    - 7.3.1.1.1. By Value
  - 7.3.1.2. Market Share & Forecast
    - 7.3.1.2.1. By Offering Type
    - 7.3.1.2.2. By Technology
    - 7.3.1.2.3. By Application
    - 7.3.1.2.4. By End-User
- 7.3.2. Germany Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 7.3.2.1. Market Size & Forecast
    - 7.3.2.1.1. By Value
  - 7.3.2.2. Market Share & Forecast
    - 7.3.2.2.1. By Offering Type
    - 7.3.2.2.2. By Technology
    - 7.3.2.2.3. By Application
    - 7.3.2.2.4. By End-User
- 7.3.3. United Kingdom Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 7.3.3.1. Market Size & Forecast
    - 7.3.3.1.1. By Value
  - 7.3.3.2. Market Share & Forecast
    - 7.3.3.2.1. By Offering Type
    - 7.3.3.2.2. By Technology
    - 7.3.3.2.3. By Application
    - 7.3.3.2.4. By End-User
- 7.3.4. Italy Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 7.3.4.1. Market Size & Forecast
    - 7.3.4.1.1. By Value
  - 7.3.4.2. Market Share & Forecast
    - 7.3.4.2.1. By Offering Type
    - 7.3.4.2.2. By Technology
    - 7.3.4.2.3. By Application
    - 7.3.4.2.4. By End-User
- 7.3.5. Spain Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 7.3.5.1. Market Size & Forecast
    - 7.3.5.1.1. By Value
  - 7.3.5.2. Market Share & Forecast
    - 7.3.5.2.1. By Offering Type
    - 7.3.5.2.2. By Technology
    - 7.3.5.2.3. By Application
    - 7.3.5.2.4. By End-User

8. Asia-Pacific Biomanufacturing Viral Detection and Quantifications Market Outlook

8.1. Market Size & Forecast
- 8.1.1. By Value
8.2. Market Share & Forecast
- 8.2.1. By Offering Type
- 8.2.2. By Technology
- 8.2.3. By Application
- 8.2.4. By End-User
- 8.2.5. By Country
8.3. Asia-Pacific: Country Analysis
- 8.3.1. China Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 8.3.1.1. Market Size & Forecast
    - 8.3.1.1.1. By Value
  - 8.3.1.2. Market Share & Forecast
    - 8.3.1.2.1. By Offering Type
    - 8.3.1.2.2. By Technology
    - 8.3.1.2.3. By Application
    - 8.3.1.2.4. By End-User
- 8.3.2. India Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 8.3.2.1. Market Size & Forecast
    - 8.3.2.1.1. By Value
  - 8.3.2.2. Market Share & Forecast
    - 8.3.2.2.1. By Offering Type
    - 8.3.2.2.2. By Technology
    - 8.3.2.2.3. By Application
    - 8.3.2.2.4. By End-User
- 8.3.3. South Korea Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 8.3.3.1. Market Size & Forecast
    - 8.3.3.1.1. By Value
  - 8.3.3.2. Market Share & Forecast
    - 8.3.3.2.1. By Offering Type
    - 8.3.3.2.2. By Technology
    - 8.3.3.2.3. By Application
    - 8.3.3.2.4. By End-User
- 8.3.4. Japan Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 8.3.4.1. Market Size & Forecast
    - 8.3.4.1.1. By Value
  - 8.3.4.2. Market Share & Forecast
    - 8.3.4.2.1. By Offering Type
    - 8.3.4.2.2. By Technology
    - 8.3.4.2.3. By Application
    - 8.3.4.2.4. By End-User
- 8.3.5. Australia Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 8.3.5.1. Market Size & Forecast
    - 8.3.5.1.1. By Value
  - 8.3.5.2. Market Share & Forecast
    - 8.3.5.2.1. By Offering Type
    - 8.3.5.2.2. By Technology
    - 8.3.5.2.3. By Application
    - 8.3.5.2.4. By End-User

9. South America Biomanufacturing Viral Detection and Quantifications Market Outlook

9.1. Market Size & Forecast
- 9.1.1. By Value
9.2. Market Share & Forecast
- 9.2.1. By Offering Type
- 9.2.2. By Technology
- 9.2.3. By Application
- 9.2.4. By End-User
- 9.2.5. By Country
9.3. South America: Country Analysis
- 9.3.1. Brazil Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 9.3.1.1. Market Size & Forecast
    - 9.3.1.1.1. By Value
  - 9.3.1.2. Market Share & Forecast
    - 9.3.1.2.1. By Offering Type
    - 9.3.1.2.2. By Technology
    - 9.3.1.2.3. By Application
    - 9.3.1.2.4. By End-User
- 9.3.2. Argentina Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 9.3.2.1. Market Size & Forecast
    - 9.3.2.1.1. By Value
  - 9.3.2.2. Market Share & Forecast
    - 9.3.2.2.1. By Offering Type
    - 9.3.2.2.2. By Technology
    - 9.3.2.2.3. By Application
    - 9.3.2.2.4. By End-User
- 9.3.3. Colombia Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 9.3.3.1. Market Size & Forecast
    - 9.3.3.1.1. By Value
  - 9.3.3.2. Market Share & Forecast
    - 9.3.3.2.1. By Offering Type
    - 9.3.3.2.2. By Technology
    - 9.3.3.2.3. By Application
    - 9.3.3.2.4. By End-User

10. Middle East and Africa Biomanufacturing Viral Detection and Quantifications Market Outlook

10.1. Market Size & Forecast
- 10.1.1. By Value
10.2. Market Share & Forecast
- 10.2.1. By Offering Type
- 10.2.2. By Technology
- 10.2.3. By Application
- 10.2.4. By End-User
- 10.2.5. By Country
10.3. MEA: Country Analysis
- 10.3.1. South Africa Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 10.3.1.1. Market Size & Forecast
    - 10.3.1.1.1. By Value
  - 10.3.1.2. Market Share & Forecast
    - 10.3.1.2.1. By Offering Type
    - 10.3.1.2.2. By Technology
    - 10.3.1.2.3. By Application
    - 10.3.1.2.4. By End-User
- 10.3.2. Saudi Arabia Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 10.3.2.1. Market Size & Forecast
    - 10.3.2.1.1. By Value
  - 10.3.2.2. Market Share & Forecast
    - 10.3.2.2.1. By Offering Type
    - 10.3.2.2.2. By Technology
    - 10.3.2.2.3. By Application
    - 10.3.2.2.4. By End-User
- 10.3.3. UAE Biomanufacturing Viral Detection and Quantifications Market Outlook
  - 10.3.3.1. Market Size & Forecast
    - 10.3.3.1.1. By Value
  - 10.3.3.2. Market Share & Forecast
    - 10.3.3.2.1. By Offering Type
    - 10.3.3.2.2. By Technology
    - 10.3.3.2.3. By Application
    - 10.3.3.2.4. By End-User

11. Market Dynamics

11.1. Drivers
11.2. Challenges

12. Market Trends & Developments

12.1. Recent Developments
12.2. Product Launches
12.3. Mergers & Acquisitions

13. PESTLE Analysis

14. Porter's Five Forces Analysis

14.1. Competition in the Industry
14.2. Potential of New Entrants
14.3. Power of Suppliers
14.4. Power of Customers
14.5. Threat of Substitute Product

15. Competitive Landscape

15.1. Danaher Corporation
- 15.1.1. Business Overview
- 15.1.2. Company Snapshot
- 15.1.3. Products & Services
- 15.1.4. Financials (As Reported)
- 15.1.5. Recent Developments
- 15.1.6. Key Personnel Details
- 15.1.7. SWOT Analysis
15.2. Merck KGaA
15.3. New England Biolabs
15.4. TAKARA HOLDINGS INC.
15.5. Thermo Fisher Scientific Inc.
15.6. Agilent Technologies, Inc.
15.7. Sartorius AG
15.8. Charles River Laboratories
15.9. Bio-Rad Laboratories, Inc.
15.10. PerkinElmer, Inc